Clinical Trials Nct Page
Clinical Trial Results:
A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION WITH RIBAVIRIN IN INTERFERON ALFA NAIVE SUBJECTS WITH CHRONIC HEPATITIS C GENOTYPE 1
| Summary | |
EudraCT number | 2005-000867-24 |
Trial protocol | DE CZ |
Global completion date | 10 May 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 27 Jan 2019 |
First version publication date | 27 Jan 2019 |
Other versions | |
Summary report(s) | gsk-alfr-hc-04-synopsis-redact |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.